GET DAILY SIGNALSEcovyst (ECVT) Reports +51% Sales Growth in Q3 2026 With Raised Full-Year Outlook
Key Takeaways
- Ecovyst reported third-quarter 2026 sales of $308.6 million, up 51% year over year from $204.9 million.
- Adjusted EBITDA rose 6% to $61.2 million, above the high end of management's guidance.
- Adjusted diluted earnings per share came in at $0.23, ahead of the consensus estimate of $0.21; GAAP diluted EPS from continuing operations was $0.17.
- Management raised its full-year 2026 outlook for the third consecutive quarter, with Adjusted EBITDA now guided to $208 million to $212 million.
- Revenue growth was flattered by the pass-through of higher sulfur costs and the June 30 acquisition of Calabrian, while margin compression reflects that pass-through dynamic.
Why These Results Matter in Context
Ecovyst's third-quarter 2026 report carries particular weight because it marks the first full quarter of contribution from the Calabrian sulfur dioxide business acquired on June 30, 2026, and follows the December 2025 divestiture of its Advanced Materials & Catalysts segment. The results provide a clearer view of the company's focused portfolio in regenerated and virgin sulfuric acid, serving North American refining, mining, and industrial customers. Strong refining margins, solid copper-mining demand, and favorable pricing have supported momentum through 2026. At the same time, sharply higher sulfur costs are boosting the top line through pass-through pricing while compressing reported margins, which makes Adjusted EBITDA a key measure of underlying performance. I also checked this using Tickeron’s AI Screener to compare the stock against peers in the sector.
Breaking Down the Reported Numbers
Ecovyst reported third-quarter 2026 sales of $308.6 million, an increase of $103.7 million, or 51%, from $204.9 million in the year-ago quarter. The gain reflected higher sales volume for both virgin and regenerated sulfuric acid, favorable pricing, the contribution from the Calabrian acquisition, and roughly $67 million from the pass-through of higher sulfur costs.
Adjusted EBITDA rose 6% to $61.2 million, compared with $57.5 million a year earlier, above the high end of the company's guidance range. Adjusted EBITDA margin narrowed to 19.8% from 28.1%, a decline driven primarily by the mechanical effect of sulfur pass-through on revenue without a corresponding EBITDA benefit. From what I see, this dynamic is worth monitoring closely in future quarters.
Net income from continuing operations was $18.4 million, or $0.17 per diluted share, compared with $0.2 million in the prior-year quarter. On an adjusted basis, net income was $25.3 million, or $0.23 per diluted share, exceeding the consensus estimate of $0.21. Revenue also topped analyst expectations. For the first nine months of 2026, sales rose 47.6% to $773.6 million, with net income of $30.3 million versus a net loss of $76.9 million a year ago.
Market Reaction and Sentiment
Investor sentiment heading into the report was cautiously optimistic, given ECVT's track record of beating and raising guidance through 2026. The results extended that pattern, with adjusted EPS and revenue both topping consensus and management lifting its full-year outlook for the third consecutive quarter. However, the reaction has been tempered by the quality of the growth: a 51% sales increase translated into only a 6% rise in Adjusted EBITDA, as sulfur pass-through and the Calabrian acquisition flattered the top line. Analysts have also noted that part of the guidance increase stems from deferring a plant turnaround into early 2027, and that Adjusted EBITDA growth has decelerated from 87% in the first quarter to roughly 6% in the third.
Looking Ahead: Outlook and Factors to Watch
For the fourth quarter, management anticipates Adjusted EBITDA in the range of $54 million to $58 million, supported by expectations of high refinery utilization and healthy alkylate demand through year-end. Full-year 2026 guidance was raised across the board, including sales of $1.05 billion to $1.07 billion and Adjusted EBITDA of $208 million to $212 million.
Investors should watch several factors in the coming quarters. First, sulfur pricing remains a key swing variable: management expects modestly lower sulfur costs for the balance of the year, but a significant price decline could trigger short-term customer destocking. Second, the Calabrian integration is still underway, and the company has said it remains on track to capture anticipated synergies. I’m watching this closely as integration progress could influence near-term results.
Balance-sheet dynamics also warrant attention. The net debt leverage ratio rose to 2.1x from 1.2x at the end of 2025, reflecting a $100 million increase in the term loan tied to the Calabrian acquisition. Finally, the deferral of a fourth-quarter turnaround into early 2027 means next year's schedule will carry heavier maintenance activity, which could temper the cadence of near-term earnings growth even as end-market demand remains solid.
Using Tickeron’s AI Tools for Deeper Analysis
In preparing this review, I turned to Tickeron’s AI Screener to quickly filter comparable names in chemicals and refining services and spot any emerging technical patterns. The platform’s customizable filters for fundamentals, volatility, and AI-driven signals helped surface context around ECVT’s momentum relative to peers. It is a practical way to complement traditional earnings analysis when evaluating names in this space.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ECVT's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for ECVT turned positive on October 28, 2026. Looking at past instances where ECVT's MACD turned positive, the stock continued to rise in 50 of 58 cases over the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on ECVT as a result. In 76 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
Following a +2.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECVT advanced for three days, in 203 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 61 cases where ECVT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 69%.
ECVT moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.859) is normal, around the industry mean (2.450). P/E Ratio (-18.811) is within average values for comparable stocks, (-17.964). Projected Growth (PEG Ratio) (0.820) is also within normal values, averaging (1.548). ECVT's Dividend Yield (1.284) is considerably higher than the industry average of (0.040). P/S Ratio (1.417) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. ECVT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of catalysts, specialty materials and chemicals
Industry ChemicalsSpecialty
Advertisement